Effective 30 of September 2017, Peter Greven Group, a manufacturer of oleochemical derivatives, has formed Norac Additives and acquired the assets of the additives division of US company Norac.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International